Recent News

• 03.31.2025 - Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
• 03.31.2025 - Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
• 03.21.2025 - Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan
• 03.21.2025 - Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan

Recent Filings

• 02.19.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.19.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.24.2025 - 15-12G Securities registration termination [Section 12(g)]
• 12.09.2024 - EFFECT Notice of Effectiveness
• 12.02.2024 - 8-K Current report
• 11.27.2024 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 11.27.2024 - 8-K Current report
• 11.27.2024 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 11.27.2024 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments